Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs

Clinical Pharmacokinetics
G Johnsson, C G Regårdh

Abstract

All beta-adrenoreceptor blocking drugs seem to be fairly rapidly and completely absorbed from the gastro-intestinal tract. The rate of absorption, however, appears to be lower in elderly patients and possibly also in patients with renal failure than in younger patients. The extent of bioavailability varies considerably between different beta-blockers. Some of these drugs(e.g. alprenolol and propranolol) have a low extent of bioavailability due to a high first-pass elimination effect, while pindolol and practolol for example are in influenced very little by this effect. However, as some beta-blockers from active metabolites, the bioavailability calculated as the ratio between the area under the plasma concentration time curve of unchanged drug after oral and intravenous administration does not give an accurate estimation of the fraction of the biologically active dose reaching the systemic circulation. The beta-blockers so far studied are rapidly distributed in the body. The t1/2 of distribution ranges between 5 to 30 minutes. The apparent volume of distribution varies 3- to 4-fold between the compounds but in all cases the apparent volume of distribution exceeds the physiological body space. In patients with impaired liver func...Continue Reading

Citations

Jan 1, 1982·European Journal of Clinical Pharmacology·B HallengrenE Wåhlin-Boll
Jan 1, 1983·European Journal of Clinical Pharmacology·T IshizakiK Kushida
Jan 1, 1985·European Journal of Clinical Pharmacology·N O LunellA Rane
Jan 1, 1982·European Journal of Clinical Pharmacology·F M BelpaireM Rosseneu
Jan 1, 1984·European Journal of Clinical Pharmacology·M Schäfer-KortingE Mutschler
May 1, 1980·European Journal of Clinical Pharmacology·D B BarnettS R Nahorski
Nov 9, 1978·European Journal of Clinical Pharmacology·T Ishizaki, K Tawara
Nov 9, 1978·European Journal of Clinical Pharmacology·O BrørsE Arnesen
Mar 1, 1981·European Journal of Clinical Pharmacology·G Nyberg, H Westling
Mar 1, 1981·European Journal of Clinical Pharmacology·B FlouvatJ Gregoire
Sep 1, 1979·European Journal of Clinical Pharmacology·M RadiceD Criscuolo
Nov 1, 1979·European Journal of Clinical Pharmacology·A MelanderE Wåhlin-Boll
Mar 17, 1978·European Journal of Clinical Pharmacology·R Gugler, G Bodem
Nov 16, 1978·European Journal of Clinical Pharmacology·A MelanderN O Sjöberg
Jan 1, 1983·European Journal of Clinical Pharmacology·S HögstedtA Rane
May 21, 1979·European Journal of Clinical Pharmacology·O Brørs, S Jacobsen
Jan 1, 1981·European Journal of Clinical Pharmacology·O AnderssonJ Thomis
Jan 1, 1982·European Journal of Clinical Pharmacology·U AbshagenG Endele
Jul 1, 1983·Digestive Diseases and Sciences·H AbrahamssonG Dotevall
Apr 1, 1985·Klinische Wochenschrift·M S Lennard
Feb 15, 1979·Experientia·L A SalakoA O Falase
Jul 15, 2000·Archives of Pharmacal Research·S H JungJ S Kang
Jan 1, 1982·European Journal of Drug Metabolism and Pharmacokinetics·W Kirch, K G Görg
Jan 1, 1980·European Journal of Drug Metabolism and Pharmacokinetics·W KrauseU Täuber
Aug 3, 2010·Psychopharmacology·Nicholas W Gilpin, George F Koob
Dec 5, 2012·Pharmaceutical Research·Doungdaw ChantasartS Kevin Li
Apr 13, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Vincent Lai Ming Yip, Munir Pirmohamed
May 1, 1988·Carbohydrate Research·M RudolphB Helpap
Dec 1, 1978·European Journal of Pharmacology·S R NahorskiD B Barnett
Dec 20, 1979·European Journal of Pharmacology·H LüllmannA Ziegler
Aug 29, 1980·European Journal of Pharmacology·K Sriwatanakul, S R Nahorski
Aug 1, 1990·Pharmacology, Biochemistry, and Behavior·X M Yang, A J Dunn
May 1, 1993·Pharmacology, Biochemistry, and Behavior·A L Gorman, A J Dunn
Jan 1, 1981·Pharmacology & Therapeutics·D N MiddlemissD T Greenwood
Jan 1, 1990·Pharmacology & Therapeutics·T H Pringle, J G Riddell
Dec 28, 1999·American Journal of Ophthalmology·W C StewartJ A Stewart
Jan 1, 1997·Pharmacology & Therapeutics·S M KhedunB Maharaj
Jun 12, 2012·Journal of Medicinal Chemistry·Pegah VaraminiIstvan Toth
Feb 15, 1979·The New England Journal of Medicine·S RubenfeldP O Kohler
Sep 27, 1979·The New England Journal of Medicine·J Koch-Weser
Aug 27, 1981·The New England Journal of Medicine·J Koch-Weser, William H Frishman
Sep 17, 1981·The New England Journal of Medicine·William H Frishman
Jun 29, 1999·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·W C StewartJ A Stewart
Apr 1, 1977·British Journal of Clinical Pharmacology·A J WOOD
Jun 1, 1977·British Journal of Clinical Pharmacology·J Meier, E Nüesch
Mar 1, 1979·British Journal of Clinical Pharmacology·G JenningsP I Korner
Aug 1, 1979·British Journal of Clinical Pharmacology·L WongP K Mehta
Jan 21, 1978·British Medical Journal·A MelanderP O Bitzén
Oct 1, 1981·Postgraduate Medical Journal·M J WardD C Banks
Apr 29, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Eric S WohlebJohn F Sheridan
Jun 27, 2002·Clinical Pharmacokinetics·William H Frishman, Mamata Alwarshetty
Jan 1, 1981·European Journal of Clinical Pharmacology·A P Greefhorst, C L van Herwaarden
Jan 1, 1986·European Journal of Clinical Pharmacology·B G ArendsM A van Baak
Apr 1, 1989·European Journal of Drug Metabolism and Pharmacokinetics·A BortolottiM Bonati
Jan 1, 1983·European Journal of Clinical Pharmacology·M T SmithE J Triggs
Jan 1, 1989·Pharmacology & Therapeutics·M S Lennard
Jan 1, 1980·Pharmacology & Therapeutics·B N Prichard, C W Owens
Sep 1, 1990·Journal of Internal Medicine·A M AbrahamsenK Gisholt
May 17, 1982·Klinische Wochenschrift·H R OchsG Bodem
Jan 22, 2013·Expert Opinion on Drug Metabolism & Toxicology·Alfredo Carlo AltamuraSilvio Bareggi
Dec 1, 1978·Clinical Toxicology·S M Kalman
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·J D Fitzgerald
Nov 1, 1980·Kidney International·M A Weber, J I Drayer
Feb 16, 2006·Journal of Clinical Pharmacy and Therapeutics·R Ismail, L K Teh
Jun 1, 1981·Disease-a-month : DM·J W Moses, J S Borer
Jun 1, 1983·Journal of Clinical and Hospital Pharmacy·M J Kendall, S R Smith
Jan 1, 1987·Journal of Clinical Pharmacology·J Dunn
Oct 1, 1990·Biochemical Pharmacology·S S MurthyM S Lennard
May 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M S LennardH F Woods
Feb 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·W DieterleW Theobald
Oct 1, 1980·Journal of Pharmacokinetics and Biopharmaceutics·L BalantJ Fabre
Aug 12, 1998·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A P MansurJ A Ramires
Nov 1, 1984·The American Journal of Emergency Medicine·A Heath
Oct 1, 1985·International Journal of Cardiology·R Given-Wilson, M Joy
Mar 1, 1989·Neurophysiologie clinique = Clinical neurophysiology·A D Kazis
Mar 26, 2002·Journal of Glaucoma·Alexander Y TanBalwantray C Chauhan
May 5, 2016·Circulation·Varun Sundaram, James C Fang
Oct 1, 1983·Biopharmaceutics & Drug Disposition·K K MidhaI J McGilveray
Aug 1, 1993·Journal of Clinical Pharmacy and Therapeutics·S AkhlaghiP Greenhaff
Jan 1, 1987·Fundamental & Clinical Pharmacology·P DescheJ Duchier
Jan 1, 1987·European Journal of Clinical Pharmacology·E von MöllendorffG Neugebauer
Apr 2, 2008·Journal of Computer Assisted Tomography·Harpreet K PannuElliot K Fishman
Feb 28, 2020·Chirality·Vinod Kumar Vashistha, Anuj Kumar
Jan 1, 1978·The Journal of Pharmacy and Pharmacology·P VermeijP A van Zwieten
Mar 1, 1981·The Journal of Pharmacy and Pharmacology·P B Woods, M L Robinson
Apr 1, 1983·British Journal of Clinical Pharmacology·A HeathC G Redgårdh
Jun 12, 1979·European Journal of Clinical Pharmacology·L A SalakoR A Adio
Jan 1, 1986·Acta Pharmacologica Et Toxicologica·P YlitaloH Vapaatalo
Jun 1, 1985·British Journal of Clinical Pharmacology·P J DrewS J Evans
Apr 1, 1987·Journal of Clinical Pharmacology·R D ToothakerJ R Goulet
Jan 1, 1982·Acta Anaesthesiologica Scandinavica. Supplementum·K E Andersson
Jul 1, 1985·Journal of Clinical Pharmacology·R SegaA Libretti
Jan 1, 1985·Scandinavian Journal of Gastroenterology. Supplement·E Lyrenäs
Oct 1, 1980·British Journal of Clinical Pharmacology·R GuglerG Bodem
Nov 1, 1982·British Journal of Clinical Pharmacology·R K FergusonW B Abrams
Jan 1, 1982·Acta Medica Scandinavica. Supplementum·C G Regårdh
May 1, 1981·British Journal of Pharmacology·B A Hemsworth, J A Street
Jan 1, 1977·Acta Medica Scandinavica. Supplementum·J Meier
Sep 1, 1981·British Journal of Clinical Pharmacology·C S DeaconG T Tucker
Nov 15, 2016·Journal of Clinical and Experimental Neuropsychology·Rachel M ZamzowDavid Q Beversdorf
Mar 1, 1989·Journal of Clinical Pharmacology·F GallettiM Mancini
Jan 1, 1982·Acta Pharmacologica Et Toxicologica·J HäggendalK Thorén-Tolling
Nov 25, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Michael González-DurruthyM Natália D S Cordeiro
Sep 3, 1977·The Medical Journal of Australia·A BobikP I Korner

Related Concepts

Adrenergic beta-Antagonists
Senility
Biological Availability
Serum Proteins
Brain
Cardiovascular Diseases
Celiac Disease
Dose-Response Relationship, Drug
Drug Interactions
Erythrocytes

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Pediculosis pubis

Pediculosis pubis is a disease caused by a parasitic insect known as Pthirus pubis, which infests human pubic hair, as well as other areas with hair including eye lashes. Here is the latest research.

Rh Isoimmunization

Rh isoimmunization is a potentially preventable condition that occasionally is associated with significant perinatal morbidity or mortality. Discover the latest research on Rh Isoimmunization here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells. It also follows CRISPR-Cas9 approaches to generating genetic mutants as a means of understanding the effect of genetics on phenotype.

Enzyme Evolution

This feed focuses on molecular models of enzyme evolution and new approaches (such as adaptive laboratory evolution) to metabolic engineering of microorganisms. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Pharmacology of Proteinopathies

This feed focuses on the pharmacology of proteinopathies - diseases in which proteins abnormally aggregate (i.e. Alzheimer’s, Parkinson’s, etc.). Discover the latest research in this field with this feed.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.